Speakers

A seasoned veteran in applying technology, data, AI and GenAI for healthcare and life sciences to drive towards better healthcare outcomes. He is passionate about generating a positive impact for patients through accelerating innovative assistive technologies such as AI as a Healthcare and Life Sciences Field-CTO.

(*1966) Antoine Hubert acquired a shareholding in the Clinique de Genolier in 2002 and founded Swiss Medical Network in 2004. Prior to this he had been active in the real-estate sector, and had established and managed numerous companies in a wide range of fields. At AEVIS VICTORIA SA and Swiss Medical Network SA he serves as Delegate of the Board, and also holds further functions and Directorships in various subsidiaries of the Group.

(*1955) Raymond Loretan studied law in Fribourg and served in the diplomatic corps for over 20 years. He was a co-founder of the Geneva-based FBL Associés consultancy. Deputy Chairman of the Board of AEVIS VICTORIA SA, he also holds Directorships in various subsidiaries of the Group.

Professor Lovis is Professor of Clinical Informatics and Director of the «Genomics and Digital Health» programme at the University of Geneva's Graduate School of Life Sciences, as well as Head of Medical Information Sciences at the Diagnostic Department of the University Hospitals of Geneva. His research focuses on the interoperability and semantics of clinical data and the analytical methods used to analyse them, particularly in relation to information and complexity theories. Christian Lovis is a member of the Innosuisse Innovation Council, the SPHN Advisory Board, the German Government's Scientific Advisory Board on Medical Research Data Infrastructure and the Israeli National Institute for Health Policy and Health Services Research (IJHPR).

Craig S. Markovitz is an Entrepreneur in Residence in the Swartz Center for Entrepreneurship and a Distinguished Service Professor of Entrepreneurship in the Tepper School of Business at Carnegie Mellon University (CMU) in Pittsburgh, Pennsylvania.  He was also the inaugural Prosser Mellon Fellow at the Richard King Mellon Foundation. Markovitz is co-founder of Blue Belt Technologies, Inc., a spinoff from the Robotics Institute at CMU and served as the company’s Chief Executive Officer for over 7 years. In this capacity, he launched the company, raised capital, managed operations, and led a January 2011 merger with HealthpointCapital.  He then transitioned to Chief Operating Officer and helped to lead substantial growth of the company from pre-revenue and 18 employees to multi-million in revenue and 150 employees.  Markovitz was a key member of the deal team that led to an acquisition by Smith and Nephew, plc in January 2016 for $275,000,000. In addition, Markovitz was Chief Executive Officer and co-founder of Spotlight Medical, Inc.  Spotlight was a spinoff company based on technology developed jointly by Carnegie Mellon University and The University of Pittsburgh.  He managed this company to a successful exit as well.  Prior to founding Blue Belt and Spotlight, Craig worked with The Redleaf Group, Inc., a $285 million early-stage venture capital fund, as the Chief Operating Officer of PenNetWorks, LLC at the University of Pennsylvania. He was the recipient of the 2019 Junior Achievement of Western PA Spirit of Enterprise Award for Entrepreneurial Achievement, the 2016 Carnegie Science Center Entrepreneur and the 2016 Pittsburgh Venture Capital Association Outstanding Entrepreneur Awards. Markovitz graduated with distinction from the MBA program at the Charles H. Kellstadt Graduate School of Business at DePaul University in Chicago with a degree in Entrepreneurship and graduated cum laude from Washington and Jefferson College in Washington, PA, with a BA in Management.  He lives in Pittsburgh, PA with his wife and family. 

Olivier Michielin holds a Master's degree in physics from EPFL and a Federal Diploma in Medicine from UNIL, which he obtained in 1997. He then joined the laboratory of Martin Karplus, the future winner of the 2013 Nobel Prize in Chemistry, at the universities of Harvard and Stasbourg, where he worked on modelling the TCR-peptide-MHC complex, obtaining an MD-PhD in 2001. On his return to Switzerland, he joined the SIB - Swiss Institute of Bioinformatics as group leader in the field of molecular modelling. At the same time, he trained in medical oncology at the CHUV. 

Appointed assistant professor at UNIL's Faculty of Biology and Medicine in 2004, he became associate professor in 2011 and full professor in 2019. At the CHUV, he was successively appointed head of the melanoma clinic, assistant physician at the multidisciplinary oncology centre and, in 2016, head physician at the Precision Oncology Centre. In 2017, together with his colleagues at the HUG and the CHUV, he launched a joint molecular tumorboard between Geneva and Vaud, a clinical platform for discussing and interpreting complex molecular data to facilitate personalized patient management. 

A specialist in precision oncology, Olivier Michielin combines basic and clinical research, in particular to integrate "multi-omics" data to determine the optimal treatment for each patient and develop new immunotherapies. In October 2022, he was appointed full professor in the Department of Medicine at the UNIGE Faculty of Medicine and head of the Department of Oncology at the HUG. He will also head the new Precision Oncology Service at the HUG and vice-coordinate the Centre for Translational Research in Onco-haematology (CRTOH) at the UNIGE Faculty of Medicine. He has also been appointed Co-Director of the SCCL, the Swiss Cancer Centre for the Lake Geneva region. Together with Prof. Bodenmiller from Zurich, he heads the national SPHN precision oncology programme.

Prisca Quadroni, LL.M., Swiss lawyer, is CEO and co-founder of AI Legal & Strategy Consulting AG, a consulting firm bridging AI integration and legal compliance for businesses. She advises executives and entrepreneurs on legal and ethical issues related to AI and proposes training and risk mitigation measures. She is President of Women Experts in AI and a board member of associations that foster AI adoption. She further acts as a legal expert for the SwissMedtech. Finally, she is engaged in the academic sector, co-leading and teaching different programmes at Swiss universities, such as ETH Zurich, University of Applied Sciences Lucerne and University of Lugano.

Dominik Steiner's passion for healthcare innovation shines through his 4 years as a Customer Engineer for Healthcare and Life Science at Google Cloud. He transforms complex health data into actionable insights, empowering European customers to revolutionise their digital healthcare landscape.

Jérôme Zürcher is a seasoned transformation expert specialising in guiding organisations through technological disruptions. He has over a decade of experience successfully helping companies acquire essential AI skills and harness their data assets to create new value streams. Jérôme's approach involves executive education to enhance AI literacy throughout organisations, coupled with coaching teams to accelerate AI innovation and drive business benefits through the deployment of impactful AI solutions. Jérôme teaches AI strategy to executive students at ETH Zurich, holds a master’s degree in physics engineering from EPFL Lausanne, and a MAS in Management, Technology and Economics from ETH. He has also completed executive education programmes in leadership, digital transformation, and strategy execution at IMD, INSEAD and IESE.